The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
IMMUNOLOGICAL INVESTIGATIONS
Volume -, Issue -, Pages 1-16
Publisher
Informa UK Limited
Online
2022-10-11
DOI
10.1080/08820139.2022.2130075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Louki Zupa decoction attenuates the airway inflammation in acute asthma mice induced by ovalbumin through IL-33/ST2-NF-κB/GSK3β/mTOR signalling pathway
- (2022) Xi Huang et al. PHARMACEUTICAL BIOLOGY
- Monocyte biology conserved across species: Functional insights from cattle
- (2022) Stephanie C. Talker et al. Frontiers in Immunology
- IL-33 biology in cancer: An update and future perspectives
- (2022) Wen Jie Yeoh et al. CYTOKINE
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway
- (2021) Xiaorong Zhou et al. Cancer Management and Research
- IL‐33/ST2 as a potential target for tumor immunotherapy
- (2021) Wenyi Jiang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention
- (2021) A.K. Saikumar Jayalatha et al. PHARMACOLOGY & THERAPEUTICS
- IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis
- (2021) Jessica E. Miller et al. JCI Insight
- Lipid-Droplet Formation Drives Pathogenic Group 2 Innate Lymphoid Cells in Airway Inflammation
- (2020) Fotios Karagiannis et al. IMMUNITY
- Insufficient CD100 shedding contributes to suppression of CD8 + T‐cell activity in non‐small cell lung cancer
- (2020) Hong‐Min Wang et al. IMMUNOLOGY
- IL-33-ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration
- (2020) Rania Dagher et al. Nature Communications
- Blood Monocyte Subsets with Activation Markers in Relation with Macrophages in Non-Small Cell Lung Cancer
- (2020) Iwona Kwiecień et al. Cancers
- Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
- (2020) Ivan Ramirez‐Moral et al. JOURNAL OF PATHOLOGY
- Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer
- (2019) Sunil Singhal et al. Science Translational Medicine
- Notch signaling suppresses CD 14 + monocytes cells activity in patients with chronic hepatitis C
- (2019) Zhi‐Hong Zhang et al. APMIS
- Interleukin-33 Involvement in Nonsmall Cell Lung Carcinomas: An Update
- (2019) Marco Casciaro et al. Biomolecules
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- IL-17–producing ST2 + group 2 innate lymphoid cells play a pathogenic role in lung inflammation
- (2018) Ting Cai et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
- (2018) Min Yang et al. PLoS One
- Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer
- (2018) Mengyao Sun et al. Oncotarget
- Interleukin-33, a Potential Cytokine Expressed in Tumor Microenvironment Involves in Antitumor Immunotherapy Through Facilitating CD8+ T Cells
- (2018) Xiaochen Li et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Interleukin-7 promotes lung-resident CD14+ monocytes activity in patients with lung squamous carcinoma
- (2018) Shuo Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- IL-33: biological properties, functions, and roles in airway disease
- (2017) Li Yin Drake et al. IMMUNOLOGICAL REVIEWS
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure
- (2017) Xing X. Du et al. LIVER INTERNATIONAL
- IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
- (2017) Kailing Wang et al. Oncotarget
- IL-33 signaling fuels outgrowth and metastasis of human lung cancer
- (2016) Chunhong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis
- (2014) L. Barrera et al. ANNALS OF ONCOLOGY
- Serum IL-33 as a Diagnostic and Prognostic Marker in Non-small Cell Lung Cancer
- (2013) Liang-An Hu et al. Asian Pacific Journal of Cancer Prevention
- Mature interleukin-33 is produced by calpain-mediated cleavage in vivo
- (2009) Morisada Hayakawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
- (2009) Dominique Talabot-Ayer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started